CSL has pulled itself back from the brink, but there’s no room for complacency as a new leadership test arrives.
While outgoing CSL chairman Brian McNamee had to handle plenty of robust feedback at the biotech giant’s annual meeting on Tuesday, there was a remarkable amount of love in the room for a company that has taken its shareholders to hell and back over the past five months.
Gift articles to anyone you choose each month when you subscribe.
Compare how 4 other independent news outlets reported on this story.
The Australian share market is likely to open lower as investors shy away from the tech bros after an overseas sell-off overnight. Follow live.
Another wipeout for stocks tied to the buildout of AI data centres is overwhelming Wall Street and more than erasing all its gains from the day before, which was its best in three months.
The US stock market has erased its early losses after absorbing big swings for Nvidia’s stock and oil prices.
Trump poised to double down on immigration crackdown and refuse concessions to new Democratic majority in Congress
